Toxic epidermal necrolysis induced by nevirapine therapy: Description of two cases and review of the literature

Journal of Infection

Volumn 43, Issue 4, 2001, Pages 246-249

  Cattelan, A M ^a   Trevenzoli, M ^b   Sasset, L ^a   Sgarabotto, D ^a   Lanzafame, M ^b   Meneghetti, F ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOGLOBULIN; LAMIVUDINE; NEVIRAPINE; PREDNISONE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALAISE; MYALGIA; NUTRITIONAL SUPPORT; PHYSICAL EXAMINATION; TOXIC EPIDERMAL NECROLYSIS;

EID: 0035700562     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2001.0902     Document Type: Article

References (27)

1. Toxic epidermal necrolysis: A review
2. Toxic epidermal necrolysis
3. Nevirapine: A review of its development, pharmacological profile and potential for clinical use
4. High dose nevirapine: Safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection
5. Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus
6. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection
7. A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy
8. A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients
9. Current clinical experience with nevirapine for HIV infection
10. Nevirapine-induced hepatitis treated with corticosteroids?
11. Nevirapine-induced fulminant hepatitis: Presentation of case and analysis of risk factors
12. Severe hepatic failure related to nevirapine treatment
13. Adverse effects associated with the use of nevirapine in HIV postexposure prophylaxis for 2 healthcare workers
14. Severe liver toxicity in patients receiving two nucleoside analogues and a non-nucleoside reverse transcriptase inhibitor
15. Hepatotoxicity in HIV-1 infected patients receiving nevirapine-containing antiretroviral therapy
16. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients The INCAS Trial
17. Comparison of twice-daily stavudine plus once-or twice-daily didanosine and nevirapine in early stages of HIV infection: The SCAN Study Group
18. Sex differences in nevirapine rash
19. Nevirapine-associated Stevens-Johnson syndrome
20. Clinical classification of cases of toxic epidermal necrolysis. Stevens-Johnson syndrome, and erytema multiforme
21. Nevirapine-induced overlap Stevens-Johnson syndrome/toxic epidermal necrolysis
22. Toxic epidermal necrolysis: An analysis of referral patterns and steroid usage
23. Burn unit treatment of acute, severe exfoliating disorders
24. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
25. Plasmapheresis in toxic epidermal necrolysis
26. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor
27. Toxic epidermal necrolysis and Steven-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?